Wagner O J, Egger B
Klinik für Viszerale- und Transplantationschirurgie, Inselspital, Universität Bern, Bern.
Swiss Surg. 2003;9(3):105-13. doi: 10.1024/1023-9332.9.3.105.
Anastomotic leakage after visceral surgery is one of the most important and feared complication. According to the literature the rate of clinically apparent anastomotic leakage ranges from 3.4% to as high as 12% and at least one third of the mortality after colorectal surgery is attributed to leaks at the anastomotic site. Within this context, knowledge of factors influencing anastomotic healing appears even more important. Beside surgical-technical (suture technique, suture material) and surgical-tactical factors (primary anastomosis vs. discontinuity resection or formation of protective diverting stomas) knowledge of the various endogenous (diabetes, sepsis, infection, malnutrition) and exogenous factors (steroids, radiation, preoperative bowel preparation) influencing anastomotic healing is essential. Recently, it has been demonstrated that Mycophenolate mofetil, an immunosuppressive drug that is currently used in transplantation and in chronic inflammatory diseases significantly impairs mechanical stability of the healing anastomosis. In contrary, local application of keratinocyte growth factor (KGF) as well as insulin-like growth factor-I (IGF-I) have been shown to accelerate and improve anastomotic healing and mechanical stability in an animal model. Studies that will identify further factors and drugs influencing anastomotic healing are of great importance since the use of such drugs could have enormous clinical implications. The traditional use of temporary diverting stomas following operations such as coloanal anastomosis or ileopouch anastomosis as well as Hartmann's discontinuity resection could be eliminated even in immunocompromised or other high risk patients.
内脏手术后的吻合口漏是最重要且令人恐惧的并发症之一。根据文献报道,临床上明显的吻合口漏发生率在3.4%至高达12%之间,结直肠手术后至少三分之一的死亡率归因于吻合口部位的渗漏。在此背景下,了解影响吻合口愈合的因素显得尤为重要。除了手术技术(缝合技术、缝合材料)和手术策略因素(一期吻合与间断切除或形成保护性转流造口)外,了解影响吻合口愈合的各种内源性(糖尿病、脓毒症、感染、营养不良)和外源性因素(类固醇、放疗、术前肠道准备)至关重要。最近有研究表明,霉酚酸酯这种目前用于移植和慢性炎症性疾病的免疫抑制药物会显著损害愈合中吻合口的机械稳定性。相反,在动物模型中,局部应用角质形成细胞生长因子(KGF)以及胰岛素样生长因子-I(IGF-I)已被证明可加速并改善吻合口愈合及机械稳定性。确定影响吻合口愈合的其他因素和药物的研究非常重要,因为使用这类药物可能会产生巨大的临床影响。即使在免疫功能低下或其他高危患者中,也可不再传统地在诸如结直肠吻合术、回肠储袋吻合术以及哈特曼间断切除术后使用临时转流造口。